A carregar...
Drug treatment of primary hyperparathyroidism: use of clodronate disodium.
Clodronate disodium (dichloromethylene diphosphonate), a specific inhibitor of bone resorption, was given by mouth (1.0-3.2 g daily) to nine patients with primary hyperparathyroidism for two to 32 weeks so that its clinical and metabolic effects could be evaluated. Bone resorption decreased in all p...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1983
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1546876/ https://ncbi.nlm.nih.gov/pubmed/6218861 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|